Phase II data on Lp(a) lowering, followed by NHLBI recommendation - PACE-CME

Phase II data on Lpa lowering followed by NHLBI recommendation

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

Lp(a) and immune metabolism
Lp(a) and immune metabolism
The Imminent danger of Lp(a): Time to face to challenge
Lp(a) and immune metabolism
- Jeffrey Kroon, PhD
Prevalence and relevance of elevated Lp(a) in familial hypercholesterolemia
Prevalence and relevance of elevated Lp(a) in familial hypercholesterolemia
The Imminent danger of Lp(a): Time to face to challenge
Prevalence and relevance of elevated Lp(a) in familial hypercholesterolemia
- Prof. Børge Nordestgaard, MD
LDL vs Lp(a) cholesterol: confounding
LDL vs Lp(a) cholesterol: confounding
The Imminent danger of Lp(a): Time to face to challenge
LDL vs Lp(a) cholesterol: confounding
- Calvin Yeang, MD, PhD
Associations of Lp(a) with CV morbidity and mortality
Associations of Lp(a) with CV morbidity and mortality
The Imminent danger of Lp(a): Time to face to challenge
Associations of Lp(a) with CV morbidity and mortality
- Pia Kamstrup, MD, PhD